Article
Proteomic profiling of CSF reveals stage-specific changes in Amyotrophic lateral sclerosis patients
2026-04-16
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease with a heterogeneous clinical presentation, complicating early diagnosis and therapeutic monitoring. To identify disease-specific biomarkers, we performed an unbiased cerebrospinal fluid (CSF) proteomic analysis in 87 ALS patients, 89 healthy controls, and 61 neurological controls using data-independent mass spectrometry. Across...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7cdf2bf2-bfb4-548d-9612-46224b3facf6
- DOI
- 10.64898/2026.04.13.26350753
